payments were made pursuant to a contract under which the oncology group
provided physics and dosimetry services to the two hospitals. The
government learned of this matter after Baptist reported it to the
Department of Health and Human Services Office of the Inspector General.
-- Merck & Company: In February 2008, the Civil Division and U.S.
Attorneys Offices in the Eastern District of Pennsylvania and the
Eastern District of Louisiana finalized a $650 million settlement with
Merck & Company to resolve allegations that it failed to remit
legally-required rebates to Medicaid and other government health care
programs and paid illegal remuneration to health care providers to
induce them to prescribe the company's products.
-- CVS Caremark: In March 2008, CVS Caremark, which operates over 6,000
retail pharmacies throughout the United States, agreed to pay the United
States, 23 states, and the District of Columbia $36.7 million to resolve
allegations that it substituted capsules of Ranitidine (generic Zantac)
for tablets solely to significantly increase the cost and profit rather
than for any legitimate medical reason.
-- Medtronic: In May 2008, the Civil Division and the United States
Attorney for the Western District of New York reached a $75 million
settlement with Medtronic, Inc. to settle allegations that Kyphon, Inc,
which Medtronic only recently acquired, caused hospitals to submit
inflated claims for treatment associated with kyphoplasty treatment, a
minimally invasive surgical procedure used to treat spinal fractures.
Medicare Fraud Strike Force:
In May 2007, the Departments of Justice and Health and Human Services
launched the Medicare Fraud Strike Force. The Department's Fraud Sect
|SOURCE U.S. Department of Justice|
Copyright©2008 PR Newswire.
All rights reserved